 |
|||
 |
|||
| Behavior change
is fundamental to consumer-directed plans, value-based plans, and pay
for performance initiatives. While there is a body of evidence showing
that behavior change can be encouraged, there is also a body of evidence
that describes the impediment depression and anxiety can bring to
resolving health risks. Further, not all lack of behavior change can be attributed to depression and anxiety, either together or alone. Rather, financial stress from volatile economic pressures, social stress from family dynamics or substance abuse, and diagnoses of chronic disease can all be stressors that need attention. Often, however, the distress is treated with anti-depressants when depression is not the underlying condition, or the distress is under-treated when depression actually is the condition. Without recognition of the miscues in chronic care management, outcomes for chronic disease such as diabetes, heart disease, arthritis, cancer, asthma, and more can be more difficult, and much more expensive, to treat. Recognition of these stressors and the ability to distinguish between them is the subject of this intriguing seminar co-produced with the Center for Health Value Innovation. A new, validated and patented protocol for redirecting patients into depression-management coaching for adherence to interventions, or into other services that can help restore balance and competency to the individual. Hear from leaders in the Center, Chief Medical Officer Jack Mahoney MD, and President Cyndy Nayer, along with Fred Newman, CEO of Coordinated Health Solutions, provider of the patented Pharmacy Intervention Protocol (PIP). There are real-world outcomes to be shared, and questions that attendees will want to ask about outcomes-based contracting for emerging services such as these. |
|||
 |
|||
Participants will be able to:
|
|||
 |
|||
Interested attendees would
include:
Attendees would represent organizations including:
|
|||
 |
|||
 |
|||
|
|||
 |
|
Return to HealthExecWire Archive Menu
|